Angela F Braly

CIK 1321458 · Chair, President & CEO · last filed 2026-01-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$13.95M

Companies

4

Total Filings

135

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XOM Director 33,300 $164.10 $5.46M $0 11 2026-01-05
PG Director 57,977 $146.31 $8.48M $0 71 2024-06-12
LOW Director $201.19 $0 37 2021-07-02
Elevance Health, Inc. (WLP) Delisted Chair, President & CEO 510,230 $0 16 2012-03-05

Recent Filings · Page 14 of 14

135 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2008-02-08 Elevance Health, Inc. (WLP) Delisted Grant (A) +34,307 $0 EDGAR
2007-04-06 Elevance Health, Inc. (WLP) Delisted Tax (F) −1,699 -$140.3K EDGAR
2007-03-05 Elevance Health, Inc. (WLP) Delisted Mixed −1,487 -$120.2K EDGAR
2007-02-28 Elevance Health, Inc. (WLP) Delisted Tax (F) −7,167 -$581.5K EDGAR
2007-01-30 Elevance Health, Inc. (WLP) Delisted Mixed +1,770 -$34.4K EDGAR
Showing 131135 of 135
Page 14 of 14
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.